A novel model of molnupiravir against SARS-CoV-2 replication: accumulated RNA mutations to induce error catastrophe.

Zhao, Yuxi; He, Gu; Huang, Wei

Zhao, Yuxi; He, Gu; Huang, Wei.

Zhao Y; West China Hospital of Stomatology, Sichuan University, Chengdu, China.
He G; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, China. hegu@scu.edu.cn.
Huang W; State Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China. huangwei@cdutcm.edu.cn.

Signal Transduct Target Ther ; 6(1): 410, 2021 12 02.

Article in English | MEDLINE | ID: covidwho-1550274

Subject(s)

COVID-19; SARS-CoV-2; Cytidine/analogs & derivatives; Humans; Hydroxylamines; Mutation; RNA

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2021 Document Type: Article Affiliation country: S41392-021-00837-4

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google